ArticleHemaSphere2026

Dual targeting of BCMA and GPRC5D with the trispecific antibody ramantamig addresses antigenic heterogeneity in myeloma.

Chloe O'Neill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.